Buerger Disease Market information, by diagnosis (blood tests, The Allen's test, angiogram, and others), by treatment (smoking cessation, other treatments, and others), by end user- global forecast till 2030

1. Report Prologue

2. Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

2.3 Market Structure

2.4. Market Segmentation

3. Research Methodology

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

3.5 Forecast Model

4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Mega Trends

4.5 Macroeconomic Indicators

5. Market Factor analysis

5.1 Value chain analysis

5.2 Porters Five Forces analysis

5.3 Demand & Supply: Gap analysis

5.4 Pricing analysis

5.5 Investment Opportunity analysis

5.6 Merger and Acquisition landscape

5.7 Upcoming trends

6. Global Buerger’s Disease Market by Diagnosis

6.1 Blood tests

6.2 The Allen's test

6.3 Angiogram

6.3.1 CT Scan (Computerized Tomography)

6.3.2 MRI (Magnetic resonance imaging) Scan

6.3.3 X-rays

6.3.4 Others

6.4 Tissue biopsy

6.5 Others

7. Global Buerger’s Disease Market by Treatment

7.1 Smoking cessation

7.2 Smoking cessation

7.2.1 Medications

7.2.1.1 Medications to dilate blood vessels

7.2.1.2 Medications to improve blood flow

7.2.1.4 Medications to dissolve blood clots

7.2.1.5 Others

7.2.2 Intermittent compression of the arms and legs

7.2.3 Spinal cord stimulation

7.2.4 Amputation, therapeutic angiogenesis

7.2.5 Surgery

7.2.6 Others

8. Global Buerger’s Disease Market by End User

8.1 Hospital and clinics

8.2 Medical research centers

8.3 Academic institutes

8.4 Others

9. Global Buerger’s Disease Market by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 The US

9.2.1.2 Canada

9.2.2 Latin America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia

9.4.1 China

9.4.2 India

9.4.3 Japan

9.4.4 South Korea

9.4.5 Rest of Asia

9.5 Pacific

9.6 Middle East and Africa

9.6.1 UAE

9.6.2 Saudi Arabia

9.6.3 Egypt

9.6.4 Rest of Middle East and Africa

10. Competitive Landscape

11. Company Profile

12. Conclusion

12.1 Key findings

12.1.1 From CEO’s viewpoint

12.1.2 Unmet needs of the market

12.2 Key companies to watch

12.3 Prediction of Buerger’s disease Market

13. Appendix